Business description: Gland Pharma Limited

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.

Number of employees: 4,208

Sales by Activity: Gland Pharma Limited

Fiscal Period: March20192020202120222023

Pharmaceuticals

- - 34.63B 44.01B 36.25B
See all business segments

Geographical breakdown of sales: Gland Pharma Limited

Fiscal Period: March20192020202120222023

USA

- 17.58B 21.28B 23.33B 20.91B

Rest of The World (ROW)

2.19B 2.32B 5.46B 8.48B 6.89B

India

3.88B 4.67B 5.56B 8.8B 5.55B

Europe

- 1.17B 1.51B 2.4B 1.87B

Canada

- 469M 659M 829M 795M

Australia

- 131M 160M 171M 218M

New Zealand

- - - - 10.86M

North America & Europe

14.37B - - - -
See all geographic segments

Managers: Gland Pharma Limited

Insider TitleAgeSince
Chief Executive Officer 55 99-12-31
Director of Finance/CFO - 19-09-29
Chief Tech/Sci/R&D Officer - 01-12-31
Corporate Officer/Principal - 13-12-31
Corporate Officer/Principal - 19-08-11
See GLAND PHARMA LIMITED governance

Members of the board: Gland Pharma Limited

Insider TitleAgeSince
Chief Executive Officer 55 99-12-31
Director/Board Member 69 18-02-06
Director/Board Member 52 17-10-02
Director/Board Member 57 18-11-19
Composition of the Board of Directors

Shareholders: Gland Pharma Limited

NameEquities%Valuation
85,393,894 51.83 % 1 868 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
6.914 %
11,390,985 6.914 % 249 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
6.409 %
10,558,247 6.409 % 231 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
5.352 %
8,817,385 5.352 % 193 M ₹
SBI Funds Management Ltd.
3.020 %
4,974,774 3.020 % 109 M ₹
List of GLAND PHARMA LIMITED shareholders

Company details: Gland Pharma Limited

Gland Pharma Ltd.

TSIIC Phase: IV Plot No. 11 & 84

502307, Sangareddy

+91 84 5569 9999

http://www.glandpharma.com
address Gland Pharma Limited(GLAND)

Group companies: Gland Pharma Limited

NameCategory and Sector
Pharmaceuticals: Major
See all subsidiaries

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.91%-1.53%+63.44%-49.72% 3.9B
-2.04%-4.53%+88.23%+255.49% 791B
-2.16%-1.81%+64.07%+221.71% 595B
+2.31%-0.42%-8.86%-9.28% 367B
+1.03%-0.22%+15.46%+62.63% 315B
+1.65%+0.44%+22.95%+49.45% 306B
+0.07%-0.18%0.00%-20.62% 247B
+0.20%-0.25%+13.30%+47.30% 244B
+0.08%-2.83%+6.01%+15.27% 218B
+0.94%+0.25%+42.94%+37.30% 179B
Average +0.40%-0.91%+30.76%+60.95% 326.54B
Weighted average by Cap. -0.28%-2.00%+39.51%+116.88%
See all sector performances
  1. Stock Market
  2. Equities
  3. GLAND Stock
  4. Company Gland Pharma Limited